703675000: Dapagliflozin propanediol (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Sodium glucose cotransporter subtype 2 inhibitor\Dapagliflozin propanediol

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Dapagliflozin propanediol

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Substance with ether structure\Dapagliflozin propanediol

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3009016015 Dapagliflozin propanediol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009811014 Dapagliflozin propanediol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dapagliflozin propanediol	Is a	Dapagliflozin (substance)	false	Inferred relationship	Some
Dapagliflozin propanediol	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sodium glucose cotransporter subtype 2 inhibitor (disposition)	true	Inferred relationship	Some
Dapagliflozin propanediol	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Dapagliflozin (substance)	true	Inferred relationship	Some
Dapagliflozin propanediol	Is a	Sodium glucose cotransporter subtype 2 inhibitor	true	Inferred relationship	Some
Dapagliflozin propanediol	Is a	Substance with ether structure	true	Inferred relationship	Some
Dapagliflozin propanediol	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol	Inferred relationship	Some
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol	Inferred relationship	Some
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Dapagliflozin propanediol monohydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Dapagliflozin propanediol	Inferred relationship	Some
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dapagliflozin propanediol	Inferred relationship	Some	1
Dapagliflozin (as dapagliflozin propanediol) 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dapagliflozin propanediol	Inferred relationship	Some	1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dapagliflozin propanediol	Inferred relationship	Some	1
Dapagliflozin propanediol anhydrous	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Dapagliflozin propanediol	Inferred relationship	Some
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dapagliflozin propanediol	Inferred relationship	Some	2
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dapagliflozin propanediol	Inferred relationship	Some	2
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dapagliflozin propanediol	Inferred relationship	Some	2

Reference Sets

Description inactivation indicator reference set